[go: up one dir, main page]

LU87613A1 - Nouvelles compositions opthalmiques a base d'une cyclosporine - Google Patents

Nouvelles compositions opthalmiques a base d'une cyclosporine Download PDF

Info

Publication number
LU87613A1
LU87613A1 LU87613A LU87613A LU87613A1 LU 87613 A1 LU87613 A1 LU 87613A1 LU 87613 A LU87613 A LU 87613A LU 87613 A LU87613 A LU 87613A LU 87613 A1 LU87613 A1 LU 87613A1
Authority
LU
Luxembourg
Prior art keywords
eye
composition
component
compositions
composition according
Prior art date
Application number
LU87613A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87613A1 publication Critical patent/LU87613A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
LU87613A 1988-10-26 1989-10-26 Nouvelles compositions opthalmiques a base d'une cyclosporine LU87613A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US26286688 1988-10-26

Publications (1)

Publication Number Publication Date
LU87613A1 true LU87613A1 (fr) 1991-05-07

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87613A LU87613A1 (fr) 1988-10-26 1989-10-26 Nouvelles compositions opthalmiques a base d'une cyclosporine

Country Status (24)

Country Link
JP (1) JPH02164830A (lv)
KR (1) KR900005973A (lv)
AU (1) AU626928B2 (lv)
BE (1) BE1003578A4 (lv)
CA (1) CA2001502A1 (lv)
CH (1) CH679210A5 (lv)
DE (1) DE3935517A1 (lv)
DK (1) DK531289A (lv)
ES (1) ES2020032A6 (lv)
FI (1) FI895064A0 (lv)
FR (1) FR2638089A1 (lv)
GB (1) GB2224205B (lv)
GR (1) GR1000611B (lv)
HU (1) HU203046B (lv)
IL (1) IL92120A (lv)
IT (1) IT1237824B (lv)
LU (1) LU87613A1 (lv)
MY (1) MY106271A (lv)
NL (1) NL8902657A (lv)
NO (1) NO894266L (lv)
NZ (1) NZ231131A (lv)
PT (1) PT92120B (lv)
SE (1) SE8903583L (lv)
ZA (1) ZA898140B (lv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ES2098739T3 (es) 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0589843B1 (en) 1992-09-25 2001-11-28 Novartis AG Pharmaceutical compositions containing cyclosporins
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ES2177652T3 (es) 1994-11-03 2002-12-16 Novartis Ag Nuevas formas de preparacion de ciclosporina para la aplicacion oral con composicion simple y alta biodisponibilidad, y procedimiento para su obtencion.
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
RU2211047C2 (ru) 1997-01-30 2003-08-27 Новартис Аг Желатиновые капсулы с твердым покрытием, включающие фармацевтические композиции, практически не содержащие масел
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) * 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
EP2214644B1 (en) * 2007-11-05 2013-03-20 Bausch & Lomb Incorporated Water-immiscible materials as vehicles for drug delivery
KR101778316B1 (ko) * 2009-06-05 2017-09-13 알러간, 인코포레이티드 인공 눈물 및 치료학적 용도
AU2015353701B2 (en) 2014-11-25 2021-03-25 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
AU626928B2 (en) 1992-08-13
GB2224205B (en) 1992-04-15
SE8903583D0 (sv) 1989-10-26
SE8903583L (sv) 1990-04-27
PT92120A (pt) 1990-04-30
GR1000611B (el) 1992-08-31
GR890100690A (en) 1990-11-29
HU895444D0 (en) 1990-01-28
AU4371589A (en) 1990-05-03
IL92120A (en) 1994-02-27
NL8902657A (nl) 1990-05-16
DK531289D0 (da) 1989-10-25
NO894266D0 (no) 1989-10-26
GB8924040D0 (en) 1989-12-13
HU203046B (en) 1991-05-28
ES2020032A6 (es) 1991-07-16
ZA898140B (en) 1991-06-26
DK531289A (da) 1990-04-27
FR2638089A1 (fr) 1990-04-27
PT92120B (pt) 1995-06-30
KR900005973A (ko) 1990-05-07
JPH02164830A (ja) 1990-06-25
IT1237824B (it) 1993-06-18
CA2001502A1 (en) 1990-04-26
GB2224205A (en) 1990-05-02
NO894266L (no) 1990-04-27
IL92120A0 (en) 1990-07-12
BE1003578A4 (fr) 1992-04-28
IT8948485A0 (it) 1989-10-26
CH679210A5 (lv) 1992-01-15
FI895064A0 (fi) 1989-10-25
NZ231131A (en) 1992-06-25
HUT52394A (en) 1990-07-28
DE3935517A1 (de) 1990-05-03
MY106271A (en) 1995-04-29

Similar Documents

Publication Publication Date Title
BE1003578A4 (fr) Nouvelles compositions ophtalmiques a base d'une cyclosporine.
US11324757B2 (en) Pharmaceutical composition for treatment of increased intraocular pressure
US5294604A (en) Method of treating ocular diseases by periocular administration of cyclosporine A or G
US5951971A (en) Ophthalmic compositions
RU2048812C1 (ru) Способ лечения воспалительных заболеваний глаза и средство для лечения воспалительных заболеваний глаза
KR20070094600A (ko) 안질환 치료제
JP6824270B2 (ja) 生物活性親油性化合物を有するｐｅｇ化脂質ナノ粒子
EP2968139B1 (en) Microemulsion topical delivery platform
EA019867B1 (ru) Водные офтальмологические препараты
US20230398065A1 (en) Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
FR2642650A1 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines
Liang et al. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay
CN117582396A (zh) 局部眼用制剂的用途
JP2022546980A (ja) ブドウ膜炎の治療のための眼科用組成物
JP2019519479A (ja) 網膜神経変性疾患の眼局所治療のためのジペプチジルペプチダーゼ−４阻害剤
JP4475802B2 (ja) 緑内障の局所治療用フルナリジンの使用法
van Sorge et al. Flurbiprofen, S (+), eyedrops: formulation, enantiomeric assay, shelflife and pharmacology
CA3080166A1 (en) Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
JP2023529190A (ja) シスチン症の治療
Arun Raj et al. Comparative Evaluation of Corneal Permeation of Indomethacin Using Different Vegetable Oil. Research & Reviews: A Journal of Pharmaceutical Science. 2021; 12 (2): 7–12p
EP4167965A1 (en) Use of high molecular weight hyaluronic acid as ocular transporting vehicle
US20210228595A1 (en) Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
FR2752736A1 (fr) Utilisation d'antagonistes 5-ht4 dans la regulation de la secretion de corticosteroides